Journal of Infection

Article	Citations
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19	1940
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis	1490
Co-infections in people with COVID-19: a systematic review and meta-analysis	1022
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients	961
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up	784
Characteristics of COVID-19 infection in Beijing	726
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19	719
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis	678
Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China	655
The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2	557
Clinical progression of patients with COVID-19 in Shanghai, China	545
SARS-CoV-2 detection, viral load and infectivity over the course of an infection	538
Saliva is a reliable tool to detect SARS-CoV-2	512
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19	501
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study	422
COVID-19 spike-host cell receptor GRP78 binding site prediction	360
Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries	353
Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2	345
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study	337
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact	317
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19	283
Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children	268
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation	262
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients	244
Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patient	238

The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis	225
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China	225
Emergence of a new SARS-CoV-2 variant in the UK	212
Severe air pollution links to higher mortality in COVID-19 patients: The “double-hit” hypothesis.	199
CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China	199
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva	199
Coronavirus 2019-nCoV: A brief perspective from the front line	193
Current epidemiological and clinical features of COVID-19; a global perspective from China	191
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?	178
Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy	177
Profile of specific antibodies to SARS-CoV-2: The first report	174
Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis	168
SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes	168
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19	168
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study	166
High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients	164
Environmental contamination of SARS-CoV-2 in healthcare premises	164
Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies	147
How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review	143
Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19	142
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients	141
Interleukin-6 as prognosticator in patients with COVID-19	136
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients	135
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study	134
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2	133
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics	130
The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination	130
Household transmission of SARS-CoV-2	126
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure	126
Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission	126
Viral dynamics of SARS-CoV-2 in saliva from infected patients	123
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis	122
Risk factors associated with disease severity and length of hospital stay in COVID-19 patients	120
Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK	116
The duration of infectiousness of individuals infected with SARS-CoV-2	110
Regional air pollution persistence links to COVID-19 infection zoning	110
Transmission of monkeypox virus through sexual contact – A novel route of infection	109
Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis	108
A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis	107
Household transmission of COVID-19-a systematic review and meta-analysis	107
Breast milk microbiota: A review of the factors that influence composition	106
Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects	105
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients	104
SARS-CoV-2 (COVID-19) superspreader events	104
Serum ferritin as an independent risk factor for severity in COVID-19 patients	101
Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19	100
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review	99
Post-COVID-19 functional status six-months after hospitalization	93
Excess mortality due to COVID-19 in Germany	93
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers	92

Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis	92
Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patients	91
Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden – a systematic review	90
Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019	87
Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection	86
Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load	85
Antibody titers and protection against a SARS-CoV-2 infection	82
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection	82
The lung tissue microbiota features of 20 deceased patients with COVID-19	82
Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge	81
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients	80
Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecological analysis of 65 countries	80
Temperature-dependent surface stability of SARS-CoV-2	79
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups	78
Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals	77
Prolonged virus shedding even after seroconversion in a patient with COVID-19	75
Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients	75
Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study	73
Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19	73
Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus	69
Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: A meta-analysis	68
Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis	68
Corona Virus Disease 2019, a growing threat to children?	67
Increased risk of SARS-CoV-2 infection in staff working across different care homes: enhanced CoVID-19 outbreak investigations in London care Homes	67
Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration	65
The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants: A systematic review	64
Evidence for lack of transmission by close contact and surface touch in a restaurant outbreak of COVID-19	62
SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study	61
SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July-December 2020, England	61
Clinical and epidemiological features of COVID-19 family clusters in Beijing, China	61
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers	60
Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV	60
A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection	60
Rapid Salivary Test suitable for a mass screening program to detect SARS-CoV-2: A diagnostic accuracy study	59
Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary	59
Setting the criteria for SARS-CoV-2 reinfection – six possible cases	59
Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study	59
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis	59
The estimation of diagnostic accuracy of tests for COVID-19: A scoping review	59
Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks	58
Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources	58
Personal respirators for population level control of the COVID19 pandemic	57
The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection	57
Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19)	57
Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK	57
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort	57
Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui, China	55
Clinical metagenomic sequencing for diagnosis of pulmonary tuberculosis	55
Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis	55
The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia	54
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients	53
Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France	53
The potential indicators for pulmonary fibrosis in survivors of severe COVID-19	52
The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19	52
Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19	52
Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients	52
Clinical and transmission dynamics characteristics of 406 children with coronavirus disease 2019 in China: A review	52
Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test	51
Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals	50
Breastfeeding Risk from Detectable Severe Acute Respiratory Syndrome Coronavirus 2 in Breastmilk	50
COVID-19 associated invasive candidiasis	50
Improving antibiotic stewardship in COVID-19: Bacterial co-infection is less common than with influenza	50
Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative	49
Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers	49
Effect of early application of social distancing interventions on COVID-19 mortality over the first pandemic wave: An analysis of longitudinal data from 37 countries	49
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England	49
The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates	49
Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan	49
Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study	49
Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19	49
China empowers Internet hospital to fight against COVID-19	48
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening	48
Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study	48
Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China	47
Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series	47
The presence of Pneumocystis jirovecii in critically ill patients with COVID-19	47
Risk communication on behavioral responses during COVID-19 among general population in China: A rapid national study	47
Disease severity during SARS-COV-2 reinfection: a nationwide study	46
Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021	45
Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays	45

Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis	45
Antibiotic exposure and adverse long-term health outcomes in children: A systematic review and meta-analysis	44
Trend and forecasting of the COVID-19 outbreak in China	44
Efficacy and safety of Paxlovid for COVID-19:a meta-analysis	44
A large scale waterborne Campylobacteriosis outbreak, Havelock North, New Zealand	44
The COVID-19 pandemic and the true incidence of Tuberculosis in Japan	43
Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: A preliminary report.	43
Cardiovascular complications in COVID-19: A systematic review and meta-analysis	43
Outbreak of COVID-19 in a nursing home in Madrid	42
CD4+T, CD8+T counts and severe COVID-19: A meta-analysis	42
Mesenchymal stem cell therapy in severe COVID-19: A retrospective study of short-term treatment efficacy and side effects	42
Sources and transmission routes of campylobacteriosis: A combined analysis of genome and exposure data	42
Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown	42
Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care	42
Complications and mortality of typhoid fever: A global systematic review and meta-analysis	41
Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease	41
Reactivation of COVID-19 pneumonia: A report of two cases	41
In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy	41
Rotavirus and autoimmunity	40
Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.	40
TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis	40
Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer	40
Risk factors for Coronavirus disease-associated mucormycosis	40
Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months	40
Emergence of co-infection of COVID-19 and dengue: A serious public health threat	40
Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study	40
Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review	40
Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study	40
Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19	40
Water scarcity and COVID-19 in sub-Saharan Africa	40
The COVID-19 pandemic and tuberculosis in Taiwan	40
Changes in paediatric respiratory infections at a UK teaching hospital 2016–2021; impact of the SARS-CoV-2 pandemic	40
Decrease in norovirus infections in Germany following COVID-19 containment measures	39
Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India	39
Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: Preliminary prospective study	39
Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19	39
Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison	39
Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: Data from an integrated health care network	38
Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): A meta-analysis	38
Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination	38
The association between severe or dead COVID-19 and autoimmune diseases: A systematic review and meta-analysis	38
Monkeypox infection among men who have sex with men: PCR testing on seminal fluids	37
First case of monkeypox virus, SARS-CoV-2 and HIV co-infection	37
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.	37
Rethinking pandemic preparation: Global Health Security Index (GHSI) is predictive of COVID-19 burden, but in the opposite direction	37
IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression	37
Transmission of SARS-CoV-2 in the household setting: A prospective cohort study in children and adults in England	37
Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department	36
Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals	35
Public health effects of travel-related policies on the COVID-19 pandemic: A mixed-methods systematic review	35
Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection	35
COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy	34
Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2	34
COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome	34
Healthcare-associated COVID-19 in England: A national data linkage study	34
Evidence of SARS-CoV-2 re-infection with a different genotype	34
Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19)	34
Reliability and usefulness of a rapid IgM‐IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report.	34
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end?	34
Mobile health technology combats COVID-19 in China	34
Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19	34
Prior presumed coronavirus infection reduces COVID-19 risk: A cohort study	33
Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study	33
Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery	33
Social media WeChat infers the development trend of COVID-19	33
Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017	33
Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico	33
Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection	33
The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease	33
Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19	33
Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection	32
Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration	32
Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates	32
Global magnitude of encephalitis burden and its evolving pattern over the past 30 years	32
Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network	31
Impact of Routine Infant BCG Vaccination on COVID-19	31
Incidence of non-typhoidal Salmonella invasive disease: A systematic review and meta-analysis	31
Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19	31
Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?	31
Detection of mobile colistin resistance gene mcr-9 in carbapenem-resistant Klebsiella pneumoniae strains of human origin in Europe	31
A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2	31
Transmission of SARS-CoV-2 by children and young people in households and schools: A meta-analysis of population-based and contact-tracing studies	31
Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance	30
Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool	30
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Pets in Wuhan, China	30
Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review	29
Predicting the diagnosis of HIV and sexually transmitted infections among men who have sex with men using machine learning approaches	29
Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England	29
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers	29
Lower household transmission rates of SARS-CoV-2 from children compared to adults	29
Epidemiological characteristics and transmission model of Corona Virus Disease 2019 in China	29
Immunocompromised children and young people are at no increased risk of severe COVID-19	29
Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19)	29
Ibrutinib suppresses intracellular mycobacterium tuberculosis growth by inducing macrophage autophagy	29
Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation	28